The IVD Market in South Korea, 2024

Report
72 Pages
February 2024
Region: South Korea
Kalorama Information
ID: 5941485

The IVD Market in South Korea, 2024 offers a comprehensive overview of the in vitro diagnostics (IVD) market in South Korea and the factors shaping it. The report presents South Korea's IVD revenues for 2023 and forecasts for 2028, segmented into clinical chemistry, immunoassay, microbiology/molecular testing, point-of-care (POC), and histology/cytology. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences.

The report is designed to provide the reader with an overview of the IVD market in South Korea and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators, and controls of the following sub-segments:

Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Hematology and hemoglobin tests are also included in this segment.
Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis, influenza).
Microbiology and Molecular Testing: manual and automated tests, culture media (to be prepared or ready to use), latex tests, transport media, blood culture, sensitivity discs, Gram and other stains, MTB culture, Mycoplasma, Ureaplasma, nucleic acid testing.
Point-of-Care Testing: all POC tests for cardiology, toxicology, coagulation, diabetes, infectious diseases. Includes POC and non-POC blood gas and electrolytes. Also includes glucose self-monitoring tests.
Histology/Cytology: PAP, HE, IHC, ISH, FISH, primary and secondary antibodies.

Scope

The information in the report was gathered using both primary and secondary research methods including interviews with industry participants and representatives, completed during the period of January 2024 and February 2024. These interviews were with government officials, medical device regulators, domestic-based distributors, health care providers and global market participants. Secondary data included the use of government databases, company literature, medical journals and reports.

All market data pertains to the South Korean IVD market at the manufacturers' level. Market data is presented for the 2023 year with forecast data provided for 2028. Compound annual growth rates (CAGRs) are provided for the 2023-2028 period.

Chapter 1: Executive Summary

Industry Overview
Scope and Methodology
South Korea Ivd Market Summary
Figure 1-1: South Korea in Vitro Diagnostic Sales by Market Segment, 2023-2028 ($M)
Company Profiles

Chapter 2: South Korea Overview

Population
Table 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (Million Persons)
Figure 2-1: Total Midyear Population by Broad Age Group: South Korea, 2010-2050 (Million Persons)
Figure 2-2: Total Number of Births in South Korea, by Year, 1990-2010 and Forecast 2020-2050
Figure 2-3: South Korea Life Expectancy at Birth in Years, 2010-2050
Health Indicators
General Health
Disease Profiles in South Korea
Table 2-2: Number of Deaths Attributed to Non-Communicable Diseases, by Type of Disease, All Sexes, 2019
Table 2-3: Top 5 Cancers Affecting South Korean Population (Ranked by Total Number of Cases), 2020
Figure 2-4: Tuberculosis - New and Relapse Case Notifications, 2000-2021
Economy and Health Spending
Figure 2-5: South Korea GDP, GDP (Ppp) and Health Spending, 1990-2020 ($B)
Figure 2-6: South Korea Distribution of Income or Consumption by Quintile, 2011-2016
Health Infrastructure
Figure 2-7: Healthcare System in Korea
Medical Facilities
Hospital Bed Density
Figure 2-8: Hospital Bed Density Per 1,000 Population, by Country, 2023 Estimates
Physicians
Figure 2-9: Physician Density Per 1,000 Population, by Country, 2023 Estimates
Medical Tourism
Figure 2-10: South Korea Medical Tourism Visits Reported, 2009-2021 (# of Patients)
Medical Device Regulation
Figure 2-11: Medical Device Approval Process, South Korea
Regulatory News
Precision Medicine and Ngs
Physician Shortage in South Korea
Table 2-4: Market Divers and Inhibitors for Entering South Korea's Medical Device Market
Figure 2-12: South Korea Medical Device Market Growth as a Global Comparison, 2023-2028 CAGR (%)

Chapter 3: Ivd Markets in South Korea

Market Summary
Table 3-1: South Korea in Vitro Diagnostic Sales, by Extracted Market Segment (Blood Bank Screening Immunoassays, Blood Gas Analysis, Blood Screening Nat, Ctc, General Chemistry, Hematology, Hemoglobin, Hpv, Id/Ast, Infectious Disease Immunoassays, Microbiology Molecular, Non-Infectious Disease Immunos, Other Histology, Poc Glucose, Poc Infectious Disease, Poc Other, Urinalysis, Others), 2023-2028 ($M)
Figure 3-1: South Korea in Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, Poc, Other), 2023-2028 ($M)
Figure 3-2: South Korea in Vitro Diagnostic Sales, by Broad Market Segment (Clinical Chemistry, Histology, Immunoassay, Microbiology, Poc, Other), 2023 Market Distribution (%)
Clinical Chemistry
Hematology
Hemoglobin
Blood Gas Analysis
Urinalysis
Figure 3-3: South Korea - Clinical Chemistry Market (Blood Gas Analysis, General Chemistries, Hematology, Hemoglobin, Urinalysis), 2023-2028
Immunoassay
Non-Infectious Disease Immunoassays
Infectious Disease Immunoassays
Figure 3-4: South Korea Immunoassay Infectious Disease Market Distribution, by Disease (Blook Bank Screening Immunos, Hais/Sepsis, Hepatitis, HIV, Mycology, Parasitology, Respiratory [W/ COVID], Std, Torch, Other [Ebv, Chagas, Dengue, Malaria, Etc.]), 2023 (%)
Blood Bank Screening Immunoassays
Figure 3-5: South Korea - Immunoassay Market Value, by Segment (Blood Bank Screening, Infectious Disease, Non-Infectious Disease), 2023-2028 ($M)
Microbiology/Molecular
Id/Ast
Figure 3-6: South Korea Id/Ast Manual, Auto Market Distribution, 2023 (%)
Molecular Diagnostics
Figure 3-7: South Korea Molecular Infectious Disease Market Distribution, by Segment (Molecular Blood Screening - Nat, Molecular Hai [C. Diff/Sepsis, Mrsa, Vre, Others], Molecular Hepatitis, Molecular HIV, Molecular Mycobacteria/Tb, Molecular Other Microbiology, Molecular Std, Respiratory W/ COVID), 2023 (%)
Blood Screening
Figure 3-8: South Korea Microbiology/Molecular Testing Market Value, by Segment (Blood Screening-Nat, Id/Ast, Molecular Dx), 2023-2028 ($M)
Point-Of-Care
Poc Glucose
Poc Infectious Disease
Figure 3-9: South Korea Poc Market Value, by Segment (Glucose, Infectious Disease, Other Poc), 2023-2028 ($M)
Histology
Hpv
Ctc
Figure 3-10: South Korea - Histology Market (Hpv, Ctc, Others), 2023-2028 ($M)

Chapter 4: Major Market Participants

Abbott Laboratories
Table 4-1: Abbott Corporate Summary
Company Overview
Becton Dickinson (Bd)
Table 4-2: Bd Corporate Summary
Company Overview
Bertis, Inc.
Table 4-3: Bertis Corporate Summary
Company Overview
Biomerieux SA
Table 4-4: Biomerieux SA Corporate Summary
Company Overview
Bio-Rad Laboratories Inc.
Table 4-5: Bio-Rad Labs Corporate Summary
Company Overview
Danaher Corporation
Table 4-6: Danaher Corporation Summary
Company Overview
Fujirebio Inc.
Table 4-7: Fujirebio Corporate Summary
Company Overview
Gencurix
Table 4-8: Gencurix Corporation Summary
Company Overview
Roche Diagnostic Corporation
Table 4-9: Roche Diagnostic Corporate Summary
Company Overview
Sd Biosensor
Table 4-10: Sd Biosensor Corporate Summary
Company Overview
Seegene, Inc.
Table 4-11: Seegene Corporate Summary
Company Overview
Siemens Healthineers GmbH
Table 4-12: Siemens Healthineers Corporate Summary
Company Overview
Sugentech
Table 4-13: Sugentech Corporate Summary
Company Overview
Sysmex Corporation
Table 4-14: Sysmex Corporate Summary
Company Overview
Thermo Fisher Scientific
Table 4-15: Thermo Fisher Corporate Summary
Company Overview

Samples

LOADING...

Companies Mentioned

Abbott Laboratories
Becton Dickinson (Bd)
Bertis, Inc.
Bio-Rad Laboratories Inc.
Biomerieux SA
Danaher Corporation
Fujirebio Inc.
Gencurix
Roche Diagnostic Corporation
Sd Biosensor
Seegene, Inc.
Siemens Healthineers GmbH
Sugentech
Sysmex Corporation
Thermo Fisher Scientific

PURCHASE OPTIONS

Single User License PDF

1 - 10 User License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4835EUR$5,000USD£4,095GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€7616EUR$7,875USD£6,450GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€10154EUR$10,500USD£8,599GBP

Scope

Table of Contents

Samples

Companies Mentioned

Related Topics

Related Reports

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)

In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

Asia Pacific In-vitro Diagnostics Market Report and Forecast 2024-2032